US 7354579
Method of treating cancer with a VEGF antagonist and an anti-proliferative agent
granted A61KA61K31/337A61K31/555
Quick answer
US patent 7354579 (Method of treating cancer with a VEGF antagonist and an anti-proliferative agent) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/337, A61K31/555, A61K33/243, A61K38/179